Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
2.98 -0.02  (-0.67%)
TradingVolume：1272.25
05-06
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Publisher：
04-29
2024
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2024
Publisher：
04-29
2024
NOTICE OF ANNUAL GENERAL MEETING
Publisher：
04-29
2024
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS INCLUDING INDEPENDENT NON-EXECUTIVE DIRECTORS WHO HAVE SERVED MORE THAN ...
Publisher：
04-29
2024
Environmental, Social and Governance Report 2023
Publisher：
04-08
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
Publisher：
03-27
2024
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
Publisher：
03-14
2024
NOTICE OF BOARD MEETING
Publisher：
03-04
2024
FIRST PATIENT ENROLLED FOR PHASE 3 CLINICAL STUDY OF THE GROUP'S INNOVATIVE FORMULATION LY01610
Publisher：
03-01
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：1272.25
2.98
-0.02  (-0.67%)
Announcement & Circular
05-06
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
04-29
2024
FORM OF PROXY FOR USE AT ANNUAL GENERAL MEETING TO BE HELD ON 28 MAY 2024
04-29
2024
NOTICE OF ANNUAL GENERAL MEETING
04-29
2024
PROPOSALS FOR GENERAL MANDATES TO ISSUE SHARES AND REPURCHASE SHARES AND RE-ELECTION OF RETIRING DIRECTORS INCLUDING INDEPENDENT NON-EXECUTIVE DIRECTORS WHO HAVE SERVED MORE THAN NINE YEARS OF THE COMPANY AND PROPOSED AMENDMENTS TO BYE-LAWS AND NOTICE OF
04-29
2024
Environmental, Social and Governance Report 2023
04-08
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024
03-27
2024
ANNUAL RESULTS ANNOUNCEMENT FOR THE YEAR ENDED 31 DECEMBER 2023
03-14
2024
NOTICE OF BOARD MEETING
03-04
2024
FIRST PATIENT ENROLLED FOR PHASE 3 CLINICAL STUDY OF THE GROUP'S INNOVATIVE FORMULATION LY01610
03-01
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024
First
1
2
3
4
5
Last